For instance, Seo et al. found that a cyclic 9-amino acid peptide (LyP-1) could bind to p32 protein and serve as a biomarker in the progression of atherosclerosis, but the binding affinity of LyP-1 was not strong enough in aorta [104,105]. This evidence concerns the gene PTPN22 and atherosclerosis.